The emerging therapy of the medication represents a exciting development in the care of the condition. Different to existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatide-peptide384744.madmouseblog.com/22766740/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment